Global Spinal Muscular Atrophy (SMA) Treatment Market


  • Type: Rare Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 365

  • Format: PPT, PDF

Global Spinal Muscular Atrophy (SMA) Treatment Market Sizwe, Share and Industry Analysis, by Product, by Distribution Channel and  Region Forecast 2019-2028


Market Overview

The Global Spinal Muscular Atrophy Treatment market size stood at around USD 1.82 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period 2019-2028

The global market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma by the Swiss drugmaker Novartis comes with a price tag of USD 2.1 million, for a one-time treatment. Despite such high costs, the severity of the disorder, which is considered the leading genetic cause of death in infants, is driving the adoption of these expensive drugs

Market Growth Drivers

The overall burden of spinal muscular atrophy is one of the highest in terms of cost and healthcare services in the rare disorder. The rising incidence of spinal muscular atrophy due to the increasing population is one of the key factor for the growth in global SMA treatment market. The increasing incidence and awareness for spinal muscular atrophy have increased remarkably which is propelling the demand for efficient therapeutic options leading to better patient outcomes. In recent times, there have been two substantial and very significant product launches in gene therapy for the treatment of spinal muscular atrophy

Spinal Muscular Atrophy Treatment Market  by Disease Type

The spinal muscular atrophy treatment market has been segmented on the basis of major disease type which are Type 1 SMA, Type 2 SMA and others. Type 1 SMA generated the highest revenue amongst the three categories in 2018 and is expected to remain dominant in terms of revenue throughout the forecast duration. Type 1 SMA is anticipated to remain the most dominant because the majority of the cases of the disorder are of this type, which has led to it dominating in terms of market share. Increasing awareness of the Type 2 SMA and increasing adoption of treatment is also anticipated to drive the growth of this type in the forecast period

1. Global Spinal Muscular Atrophy (SMA) Treatment Market Overview………….
A. Market Size
2. Market Growth Drivers……………….…………………………………..……………….
A. Growing incidence of Spinal Muscular Atrophy
B. New Product Launches with High Awareness
3. Spinal Muscular Atrophy by Disease Type………………………………………
A. Type 1 SMA
B. Type 2 SMA
C. Others
4. Global Spinal Muscular Atrophy Treatment Market Segmentation………………
A. By Product
I. Nusinersen
II. Onasemnogen Abeparvovec
B. By Distribution Channel
I. Hospital Pharmacy
II. Retail Pharmacy
III. Others
C. By Geography
I. North America Market Analysis
II. Asia-Pacific Market Analysis
III. Europe Market Analysis
IV. South America Market Analysis
V. Middle-East and Africa Market Analysis
5. Spinal Muscular Atrophy Treatment Major Market Share……………….……………..
A. Market Analysis, Insights and Forecast by Revenue
6. Competitive Landscape………………………………………………………….………..
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………….
A. Biogen Company overview, Product & Services, Strategies & Financials
B. Novartis Company overview, Product & Services, Strategies & Financials
C. Genentech Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape….…………………………………..
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Market Growth………………………………………………………….
A. Key Industry Developments
10. Conclusion

Market Segmentation

By Product:

Based on product, the market is segmented into Nusinersen and Onasemnogen Abeparvovec. Nusinersen accounted for maximum share in 2018, which is attributable to the fact that in 2018, Nusinersen was the only approved product available in the market. However, Onasemnogen Abeparvovec who gained approval in 2019, is anticipated to be launched in several markets over the periods of 2019 and 2020. Onasemnogen Abeparvovec is expected to witness growth in the coming years owing to the rising launches in the number of markets across the globe and greater patient adoption

By Distribution Channel:

By distribution channel, the global SMA treatment market is categorized into hospital pharmacies, retail pharmacies, and others. In terms of value, hospital pharmacies accounted for the leading market share in 2018, which is attributable to the fact that the majority of the medications for treatment can be only administered intravenously and can so only be done by trained medical professionals. Hence, the retail pharmacies segment registers a comparatively lower CAGR

By Region:

SMA treatment market in North America was valued at USD 854.0 million in 2018. Early approvals for SMA treatment products in the U.S., coupled with adequate reimbursement, has led to growing number of patients being treated in 2018.

Europe is expected to hold the second leading position in this market by witnessing strong growth in long-term period. As per our market research study, Asia Pacific is expected to witness relatively significant growth in terms of spinal muscular atrophy treatment market value. Funding by public and private players to improve the accessibility of high-cost treatment options is likely to augment the expansion of the market during the forecast period. For instance, in the key regions of Asia such as Japan and Hong Kong have granted the status of reimbursed access to all patients, while in China, the process of reimbursement approval is currently underway. Such a positive reimbursement scenario for spinal muscular atrophy treatment is projected to boost the expansion of the market in Asia-Pacific during the forecast period.

The rest of the world comprises of the regions of Latin America and Middle East & Africa. In Latin America, the rising incidence of the disorder among the population is boosting the spinal muscular atrophy treatment market growth. Middle East & Africa is estimated to reflect slower-to-moderate growth during the forecast period, which is attributable to the delayed diagnosis of the disorder in African countries. However, positive reimbursement policies in the region in the countries in Middle East and growing awareness for the severity of the disease are the key factors estimated to propel the revenue from Middle East & Africa spinal muscular atrophy (SMA) treatment market during the forecast period

Top Major Players

Biogen and Novartis AG accounted for the complete market share in 2018, owing to their two main products for the treatment of spinal muscular atrophy. Spinraza (Nusinersen) by Biogen and Zolgensma (Onasemnogene abeparvovec) by Novartis are the only two products approved for the treatment of this disorder. Hence, these two companies hold complete dominance in terms of the market share. The other companies such as Genentech, Inc. (F. Homann-La Roche Ltd) and Astellas Pharma hold key pipeline candidates, some of which are in the advanced stages of clinical trials.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements